As we all know, pituitary tumors are common intracranial tumors. It has been reported that the incidence of pituitary tumors in the general population is as high as 16.7%. Pituitary tumors include functional adenomas and pulmonary functional adenomas. Functional pituitary tumors are diseases that cause systemic changes, including growth hormone adenoma and adrenocorticotropic hormone adenoma, et al. Functional adenoma can lead to a series of changes in the body. Some symptoms and signs are similar to some common diseases, which may lead to missed diagnosis. If the disease is not treated in time, and even serious complications occur, the prognosis of patients will be affected. Therefore, it is of great significance to further study the mechanism and treatment of pituitary tumors, and to improve the treatment effect.
The treatment of pituitary tumors mainly includes surgery, drug therapy, and radiotherapy. With the development of new drugs and the progress of surgical techniques and equipment, early diagnosis is more and more possible, the incidence of postoperative complications is gradually reduced, the treatment effect is significantly improved, and the surgical cure rate and remission rate are gradually increased.
However, the current difficulties in the diagnosis and treatment of pituitary tumors include how to predict invasive growth, tumor recurrence, drug resistance, and how to achieve total surgical resection. The role of molecular markers in predicting pituitary tumor invasiveness has become a research hotspot in recent years. For example, the markers explored in recent years, such as matrix metalloproteinases (MMPs), vascular endothelial growth factor (VEGF), and so on. The discovery and study of these molecular markers may be promising as candidate markers. However, more studies are needed to elucidate the role of these markers in tumor invasion and their prognostic value.
Therefore, our team launched this Research Topic, hoping to strengthen the in-depth research on the basic and clinical aspects of pituitary tumors. This Research Topic hopes articles on the basic and clinical research of pituitary tumors can be submitted for publication. Studies that are primarily bioinformatics or in silico based without clinical and/or functional validation in vitro and/or in vivo will not be considered as per journal policy.
As we all know, pituitary tumors are common intracranial tumors. It has been reported that the incidence of pituitary tumors in the general population is as high as 16.7%. Pituitary tumors include functional adenomas and pulmonary functional adenomas. Functional pituitary tumors are diseases that cause systemic changes, including growth hormone adenoma and adrenocorticotropic hormone adenoma, et al. Functional adenoma can lead to a series of changes in the body. Some symptoms and signs are similar to some common diseases, which may lead to missed diagnosis. If the disease is not treated in time, and even serious complications occur, the prognosis of patients will be affected. Therefore, it is of great significance to further study the mechanism and treatment of pituitary tumors, and to improve the treatment effect.
The treatment of pituitary tumors mainly includes surgery, drug therapy, and radiotherapy. With the development of new drugs and the progress of surgical techniques and equipment, early diagnosis is more and more possible, the incidence of postoperative complications is gradually reduced, the treatment effect is significantly improved, and the surgical cure rate and remission rate are gradually increased.
However, the current difficulties in the diagnosis and treatment of pituitary tumors include how to predict invasive growth, tumor recurrence, drug resistance, and how to achieve total surgical resection. The role of molecular markers in predicting pituitary tumor invasiveness has become a research hotspot in recent years. For example, the markers explored in recent years, such as matrix metalloproteinases (MMPs), vascular endothelial growth factor (VEGF), and so on. The discovery and study of these molecular markers may be promising as candidate markers. However, more studies are needed to elucidate the role of these markers in tumor invasion and their prognostic value.
Therefore, our team launched this Research Topic, hoping to strengthen the in-depth research on the basic and clinical aspects of pituitary tumors. This Research Topic hopes articles on the basic and clinical research of pituitary tumors can be submitted for publication. Studies that are primarily bioinformatics or in silico based without clinical and/or functional validation in vitro and/or in vivo will not be considered as per journal policy.
